Accelerated atherosclerosis in autoimmune rheumatic diseases

Y Shoenfeld, R Gerli, A Doria, E Matsuura, MM Cerinic… - Circulation, 2005 - Am Heart Assoc
antibodies concomitant with larger atherosclerotic lesions that contained abundant CD4
cells. OxLDL is the type of LDL that is more likely to undergo uptake by macrophages, which …

Mechanisms of disease: atherosclerosis in autoimmune diseases

Y Sherer, Y Shoenfeld - Nature clinical practice Rheumatology, 2006 - nature.com
Atherosclerosis is a pathologic process affecting blood vessels, which leads to the
development of cardiovascular disease. The immune system is involved in atherogenesis …

Cardiac manifestations of antiphospholipid syndrome with focus on its primary form

T Kolitz, S Shiber, I Sharabi, A Winder… - Frontiers in …, 2019 - frontiersin.org
Antiphospholipid syndrome (APS) is a multisystem autoimmune disease most commonly
associated with recurrent arterial and venous thromboembolism and recurrent fetal loss …

Antibodies to high‐density lipoprotein and β2‐glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary …

J Delgado Alves, PRJ Ames, S Donohue… - Arthritis & …, 2002 - Wiley Online Library
Objective To determine the prevalence of anti–high‐density lipoprotein (anti‐HDL)
antibodies and to establish a possible relationship between anti‐HDL, anticardiolipin …

Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus

JM Kahlenberg, MJ Kaplan - Annual review of medicine, 2013 - annualreviews.org
Rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), the two most common
systemic autoimmune disorders, have both unique and overlapping manifestations. One …

Vascular abnormalities, paraoxonase activity, and dysfunctional HDL in primary antiphospholipid syndrome

M Charakida, C Besler, JR Batuca, S Sangle… - Jama, 2009 - jamanetwork.com
Context Accelerated atherosclerosis has been described in antiphospholipid syndrome, but
the vascular abnormalities and the underlying mechanisms remain unclear. Objectives To …

Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment

P Soltész, G Kerekes, H Dér, G Szücs, S Szántó… - Autoimmunity …, 2011 - Elsevier
Numerous autoimmune-inflammatory rheumatic diseases have been associated with
accelerated atherosclerosis or other types of vasculopathy leading to increased cardio-and …

Subclinical atherosclerosis in systemic lupus erythematosus (SLE): the relative contribution of classic risk factors and the lupus phenotype

Y Ahmad, J Shelmerdine, H Bodill, M Lunt, MG Pattrick… - 2007 - academic.oup.com
Objectives. We aimed to examine the strength of association between traditional
cardiovascular risk factors and carotid plaque development in systemic lupus erythematosus …

Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome

S Jimenez, MA García-Criado, D Tassies… - …, 2005 - academic.oup.com
Objective. To determine the prevalence of preclinical vascular disease and associated risk
factors in patients with systemic lupus erythematosus (SLE) or primary antiphospholipid …

Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors

CB Zeller, S Appenzeller - Current cardiology reviews, 2008 - ingentaconnect.com
Atherosclerosis is a chronic inflammatory disorder characterized by immune cell activation,
inflammation driven plaque formation and subsequent destabilization. In other disorders of …